Cost-Effectiveness Analysis ofHelicobacter pyloriDiagnostic Methods in Patients with Atrophic Gastritis

Abstract

Background. There are several diagnostic methods for Helicobacter pylori (H. pylori) infection. A cost-effective analysis is needed to decide on the optimal diagnostic method. The aim of this study was to determine a cost-effective diagnostic method in patients with atrophic gastritis (AG). Methods. A decision-analysis model including seven diagnostic methods was constructed for patients with AG diagnosed by esophagogastroduodenoscopy. Expected values of cost and effectiveness were calculated for each test. Results. If the prevalence of H. pylori in the patients with AG is 85% and CAM-resistant H. pylori is 30%, histology, stool H. pylori antigen (SHPAg), bacterial culture (BC), and urine H. pylori antibody (UHPAb) were dominated by serum H. pylori IgG antibody (SHPAb), rapid urease test (RUT), and urea breath test (UBT). Among three undominated methods, the incremental cost-effective ratios (ICER) of RUT versus SHPAb and UBT versus RUT were $214 and $1914, respectively. If the prevalence of CAM-sensitive H. pylori was less than 55%, BC was not dominated, but its H. pylori eradication success rate was 0.86. Conclusions. RUT was the most cost-effective at the current prevalence of CAM-resistant H. pylori. BC could not be selected due to its poor effectiveness even if CAM-resistant H. pylori was more than 45%.

Quercetin ameliorates Helicobacter pylori‐induced gastric epithelial cell injury by regulating specificity protein 1/lipocalin 2 axis in gastritis

“…Gastritis is an inflammation of the gastric mucosa that is usually caused by an infectious agent (Sánchez‐Fayos Calabuig et al, 2009). Globally, most cases of gastritis are caused by Helicobacter pylori (HP) (Omata et al, 2017; Wang et al, 2013), which penetrates the gastric mucosa to colonize human gastric epithelial cells, triggering a variety of gastric mucosal inflammatory reaction (Yang et al, 2021). Gastritis is able to result in ulcers and increase the risk of stomach cancer (Cheng et al, 2017).…”

Cost-effectiveness of adding a <i>Helicobacter pylori</i> antibody test to the upper gastrointestinal series in gastric cancer screening at the workplace

“…Cost-effectiveness can be determined using simulation modeling [15][16][17][18][19] . An H. pylori antibody (HPA) test screening followed by eradication treatment for employees in Japan has been shown to be more cost-effective than no screening 15) , and an HPA test followed by eradication is more cost-effective than UGI only and endoscopy only for gastric cancer 16) .…”

Quercetin from Polygonum capitatum Protects against Gastric Inflammation and Apoptosis Associated with Helicobacter pylori Infection by Affecting the Levels of p38MAPK, BCL-2 and BAX

“…More than 70% gastritis are caused by H. pylori infection, which is responsible for more than 90% of active gastritis [ 3 ]. H. pylori infection is the main cause of chronic gastritis, which is called H. pylori -associated gastritis (HAG) [ 4 , 5 ]. H. pylori infection causes gastric mucosal layer edema and neutrophil infiltration, leads to acute gastric mucosal inflammation, and then results in chronic gastritis.…”